BRPI0821523A2 - composições farmacêuticas que compreendem um complexo de inclusão formado por dissulfiram e uma ciclodextrina, úteis no tratamento da dependência de álcool e cocaína - Google Patents
composições farmacêuticas que compreendem um complexo de inclusão formado por dissulfiram e uma ciclodextrina, úteis no tratamento da dependência de álcool e cocaínaInfo
- Publication number
- BRPI0821523A2 BRPI0821523A2 BRPI0821523A BRPI0821523A BRPI0821523A2 BR PI0821523 A2 BRPI0821523 A2 BR PI0821523A2 BR PI0821523 A BRPI0821523 A BR PI0821523A BR PI0821523 A BRPI0821523 A BR PI0821523A BR PI0821523 A2 BRPI0821523 A2 BR PI0821523A2
- Authority
- BR
- Brazil
- Prior art keywords
- disulfiram
- pharmaceutical compositions
- inclusion complex
- cocaine dependence
- treating alcohol
- Prior art date
Links
- AUZONCFQVSMFAP-UHFFFAOYSA-N disulfiram Chemical compound CCN(CC)C(=S)SSC(=S)N(CC)CC AUZONCFQVSMFAP-UHFFFAOYSA-N 0.000 title 2
- 208000007848 Alcoholism Diseases 0.000 title 1
- 208000022497 Cocaine-Related disease Diseases 0.000 title 1
- 229920000858 Cyclodextrin Polymers 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title 1
- 201000007930 alcohol dependence Diseases 0.000 title 1
- 201000006145 cocaine dependence Diseases 0.000 title 1
- 229960002563 disulfiram Drugs 0.000 title 1
- 206010013663 drug dependence Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/105—Persulfides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/16—Cyclodextrin; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Addiction (AREA)
- Inorganic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Nanotechnology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL200703877A CL2007003877A1 (es) | 2007-12-28 | 2007-12-28 | Composicion farmaceutica que comprende un complejo de inclusion formado por disulfiram y una ciclodextrina; y su uso para el tratamiento de la dependencia de alcohol y cocaina. |
| PCT/IB2008/003696 WO2009083794A1 (es) | 2007-12-28 | 2008-12-23 | Composiciones farmaceuticas que comprende un complejo de inclusion formado por disulfiram y una ciclodextrina, utiles en el tratamiento de la dependencia de alcohol y cocaina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0821523A2 true BRPI0821523A2 (pt) | 2017-11-14 |
Family
ID=40261622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0821523A BRPI0821523A2 (pt) | 2007-12-28 | 2008-12-23 | composições farmacêuticas que compreendem um complexo de inclusão formado por dissulfiram e uma ciclodextrina, úteis no tratamento da dependência de álcool e cocaína |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20110021458A1 (pt) |
| EP (1) | EP2238978A1 (pt) |
| KR (1) | KR101132954B1 (pt) |
| AR (1) | AR071553A1 (pt) |
| BR (1) | BRPI0821523A2 (pt) |
| CL (1) | CL2007003877A1 (pt) |
| ES (1) | ES2364419B1 (pt) |
| MX (1) | MX2010007183A (pt) |
| PE (1) | PE20091098A1 (pt) |
| WO (1) | WO2009083794A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2808630A1 (en) | 2010-08-19 | 2012-02-23 | Buck Institute For Age Research | Methods of treating mild cognitive impairment (mci) and related disorders |
| EP2814491A4 (en) * | 2012-02-18 | 2015-08-26 | Buck Inst For Res On Aging | FORMULATIONS AND METHODS FOR TREATING OR PROPHYLAXIS OF PRE-MCI AND / OR PRE-ALZHEIMER ILLNESSES |
| EP3311843A1 (en) * | 2016-10-13 | 2018-04-25 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Compositions comprising dithiocarbamate and cyclodextrin |
| KR20220010855A (ko) | 2020-07-20 | 2022-01-27 | 재단법인 제주테크노파크 | 디설피람 및 그 유도체를 이용한 지방세포의 분화억제 효과를 갖는 비만 개선 및 치료용 약학적 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4678809A (en) * | 1985-02-01 | 1987-07-07 | Michael Phillips | Injectable fomulations of disulfiram for the treatment of alcoholism |
| US5206264A (en) * | 1991-11-04 | 1993-04-27 | Cypros Pharmaceutical Corporation | Use of disulfiram to prevent cardiovascular damage |
| US5665770A (en) * | 1993-11-05 | 1997-09-09 | Gakko Hojin Kinki Daigaku | Method for treatment of cataract with radical scavenger |
| KR20030041577A (ko) * | 2001-11-20 | 2003-05-27 | 디디에스텍주식회사 | 난용성 약물과 치환된 시클로덱스트린을 함유하는고체분산체 및 이를 함유하는 약제학적 조성물 |
| CN1376463A (zh) | 2002-03-29 | 2002-10-30 | 沈阳药科大学 | 双硫伦包合物滴眼剂及其制备方法 |
| DE602004025151D1 (de) | 2004-03-10 | 2010-03-04 | Shimoda Biotech Pty Ltd | Stabile injizierbare Diclofenac- Zubereitungen |
| US20080004260A1 (en) * | 2006-06-29 | 2008-01-03 | Transcept Pharmaceuticals, Inc. | Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditions |
-
2007
- 2007-12-28 CL CL200703877A patent/CL2007003877A1/es unknown
-
2008
- 2008-12-11 PE PE2008002049A patent/PE20091098A1/es not_active Application Discontinuation
- 2008-12-23 MX MX2010007183A patent/MX2010007183A/es active IP Right Grant
- 2008-12-23 EP EP08866361A patent/EP2238978A1/en not_active Withdrawn
- 2008-12-23 BR BRPI0821523A patent/BRPI0821523A2/pt not_active IP Right Cessation
- 2008-12-23 ES ES201090050A patent/ES2364419B1/es active Active
- 2008-12-23 US US12/811,035 patent/US20110021458A1/en not_active Abandoned
- 2008-12-23 WO PCT/IB2008/003696 patent/WO2009083794A1/es not_active Application Discontinuation
- 2008-12-23 AR ARP080105737A patent/AR071553A1/es not_active Application Discontinuation
- 2008-12-26 KR KR1020080134498A patent/KR101132954B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20090073026A (ko) | 2009-07-02 |
| CL2007003877A1 (es) | 2008-06-27 |
| WO2009083794A1 (es) | 2009-07-09 |
| AR071553A1 (es) | 2010-06-30 |
| ES2364419B1 (es) | 2012-09-19 |
| PE20091098A1 (es) | 2009-08-06 |
| EP2238978A1 (en) | 2010-10-13 |
| ES2364419A1 (es) | 2011-09-02 |
| MX2010007183A (es) | 2010-12-17 |
| US20110021458A1 (en) | 2011-01-27 |
| KR101132954B1 (ko) | 2012-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0908503A2 (pt) | partícula com um diâmetro menor que 2mm, e, composição para o tratamento de tecidos | |
| BRPI0907162A2 (pt) | Composto, composição farmacêutica e métodos para ativar procaspase executora 3, 6 e/ou 7 e para tratar um estado de doença em um mamífero | |
| BRPI0911232A2 (pt) | Métodos e composições para melhorar a saúde da planta | |
| BRPI0815170A2 (pt) | Composição farmacêutica que compreende um inibidor de sglt 2 | |
| BRPI0818625A2 (pt) | Composições de cuidados pessoais que compreendem sulfatos de undecila | |
| BRPI0813892A2 (pt) | composições que compreendem antígenos pneumococcal | |
| BRPI0716592A2 (pt) | Composição para cuidado da pele | |
| BRPI0807908A2 (pt) | Melhoramentos em composições medicinais. | |
| BRPI0921041A2 (pt) | composições e métodos que compreendem uma variante de subtilisina | |
| EP2046258A4 (en) | LUBRICATING COMPOSITIONS AND ARTICLES THEREOF | |
| CL2011001966A1 (es) | Composicion farmaceutica que comprende derivados de glucopiranosil difenilmetano como inhibidor sglt-2; forma farmaceutica que comprende una composicion farmaceutica; procedimiento de preparacion y uso en el control glucemico. | |
| BRPI0815353A2 (pt) | Compoições e dhea para o tratamento da menopausa | |
| BRPI0821537A2 (pt) | Composições de catalisador de metaloceno nanoligadas e seus produtos poliméricos | |
| BRPI0923020A2 (pt) | método de redução da recalcitrância em materiais celulósicos ou lignocelulósicos e composição. | |
| BRPI0920976A2 (pt) | Composições que melhoram a perfusão da area de infarto e metodos de restauração da lesão vascular. | |
| BRPI0809829A2 (pt) | Composição, artigo e embalagem | |
| BRPI0915284A2 (pt) | Composição famacêutica oral, método para tratar uma infecção fúngica e para tratar câncer em um mamífero, e, formulação de liberação prolongada oral | |
| ZA200810166B (en) | Phenylephrine pharmaceutical formulations and compositions for colonic absorption | |
| BRPI0821524A2 (pt) | Composições de catalisadores de metaloceno nanoligadas e seus produtos poliméricos | |
| FR2896990B1 (fr) | Composition protectrice et regenerante | |
| ES2465478T8 (es) | Composiciones farmacéuticas que comprenden brivaracetam | |
| BRPI0823288A2 (pt) | Caixa para embalagem, e, matriz de caixa para embalagem | |
| BRPI0815821A2 (pt) | Composições e métodos que empregam antagonistas nmda para alcançar um efeito poupador de anestésico. | |
| BRPI0916892A2 (pt) | produto absorvente que compreende uma goma guar catiônica modificada | |
| BR112012008072A2 (pt) | composições farmacêutica que compreendem fucanas modificadas e métodos referentes a elas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2546 DE 22-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |